Related Experiment Video
Updated: Sep 29, 2026

Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
Published on: March 2, 2014
Non-Coding Transcripts From Diversified Members of IgLec Family Protect Antiviral Effectors From Viral miRNA
Ying Huang1, Rui Shen1, Xin Huang2
1Jiangsu Province Engineering Research Center For Marine Bio-Resources Sustainable Utilization, College of Oceanography, Hohai University, Nanjing, China.
Abstract:
Immune gene families frequently produce numerous non-coding transcripts, yet their biological functions remain largely unexplored. Here, using the arthropod immunoglobulin domain-containing lectin (IgLec) family as a paradigm, we provide evidence that this complexity may reflect a critical defensive function for non-coding transcripts in antiviral immunity. IgLec is restricted to decapod infraorders (Brachyura and Astacidea), and a structurally related bacterial homolog suggests its origin may involve horizontal gene transfer. The IgLec family generates extraordinary transcript diversity through three mechanisms, multi-locus duplication, inter-locus recombination, and extensive alternative splicing, yielding both protein-coding and non-coding transcripts. Protein-coding IgLec variants restrict viral replication by inducing antimicrobial peptide expression. Upon white spot syndrome virus infection, non-coding transcripts (e.g., intron-retaining transcripts) are preferentially targeted by virus-encoded microRNA-N48, thereby protecting protein-coding isoforms from repression. Loss of these decoy transcripts compromises antiviral defense and increases host mortality. Collectively, these results reveal a decoy-based antiviral strategy in which non-coding transcripts safeguard immune effectors from pathogen subversion, uncovering an unrecognized layer of innate immunity.
Related Concept Videos
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Experimental RNAi
MicroRNAs
MicroRNAs

